HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION
US Application 62/795,203
Filed on 2019-01-22
Filed on 2019-01-22
RECOMBINANT MOLECULES CONTAINING LINKER FOR ACTIVATION OF T CELLS AND THEIR USE IN IMMUNOTHERAPY
US Application 62/819,386
Filed on 2019-03-15
Filed on 2019-03-15
Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors
US Application 62/789,650
Filed on 2019-01-08
Filed on 2019-01-08
Compositions and Methods For Treating Cancer With Anti-CD33 Immunotherapy
US Application 62/620,139
Filed on 2018-01-22
Filed on 2018-01-22
Measurement Of Heterodimer Complex Of BIM---Bcl-2, BIM---Bcl-xL, BIM---Mcl-1 And BAX---BAK As Diagnostic Test Of Patient Sensitivity To BH3 Mimetics
US Application 62/798,615
Filed on 2019-01-30
Filed on 2019-01-30
Methods Of Decreasing Influenza-induced Lethality Using Gastrin Releasing Peptide (GRP) Or Gastrin Releasing Peptide Receptor (GRPR) Antagonists
US Application 62/729,662
Filed on 2018-09-11
Filed on 2018-09-11
Cell Linkers for Heterotypic Cell Spheroids
US Application 62/698,602
Filed on 2018-07-16
Filed on 2018-07-16
Compositions And Methods For Modulation Of LMNA Expression
US Application 62/734,196
Filed on 2018-09-20
Filed on 2018-09-20
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF
US Application 62/738,317
Filed on 2018-09-28
Filed on 2018-09-28